Skip to main content

Advertisement

Log in

The role of metabolites and metabolomics in clinically applicable biomarkers of disease

  • Review Article
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Metabolomics allows the simultaneous and relative quantification of thousands of different metabolites within a given sample using sensitive and specific methodologies such as gas or liquid chromatography coupled to mass spectrometry, typically in discovery phases of studies. Biomarkers are biological characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathological processes or pharmacologic responses to a therapeutic intervention. Biomarkers are widely used in clinical practice for the diagnosis, assessment of severity and response to therapy in a number of clinical disease states. In human studies, metabolomics has been applied to define biomarkers related to prognosis or diagnosis of a disease or drug toxicity/efficacy and in doing so hopes to provide greater pathophysiological understanding of disease or therapeutic toxicity/efficacy. This review discusses the application of metabolomics in the discovery and subsequent application of biomarkers in the diagnosis and management of inborn errors of metabolism, cardiovascular disease and cancer. We critically appraise how novel biomarkers discovered through metabolomic analysis may be utilized in future clinical practice by addressing the following three fundamental questions: (1) Can the clinician measure them? (2) Do they add new information? (3) Do they help the clinician to manage patients? Although a number of novel biomarkers have been discovered through metabolomic studies of human diseases in the last decade, none have currently made the transition to routine use in clinical practice. Metabolites identified from these early studies will need to form the basis of larger, prospective, externally validated studies in clinical cohorts for their future use as biomarkers. At this stage, the absolute quantification of these biomarkers will need to be assessed epidemiologically, as will the ultimate deployment in the clinic via routine biochemistry, dip stick or similar rapid at- or near-patient care technologies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Alfieri AB, Briceno L, Fragasso G, Spoladore R, Palloshi A, Bassanelli G, Montano C, Arioli F, Cuko A, Ruotolo G, Margonato A (2008) Differential long-term effects of carvedilol on proinflammatory and antiinflammatory cytokines, asymmetric dimethylarginine, and left ventricular function in patients with heart failure. J Cardiovasc Pharmacol 52(1):49–54

    Article  CAS  PubMed  Google Scholar 

  • American Diabetes Association (2008) Diagnosis and classification of diabetes. Diabetes Care 31(Suppl 1):S55–S60

    Article  CAS  Google Scholar 

  • Anderson JL, Adams CD, Antman EM et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable Angina/Non ST-elevation myocardial infarction: a report of the American College of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol 50(7):e1–e157

    Article  PubMed  Google Scholar 

  • Arn PH (2007) Newborn screening: current status. Health Aff (Millwood) 26(2):559–566

    Google Scholar 

  • Bassand JP, Hamm CW, Ardissino D et al (2007) Task force for diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of European society of cardiology. Guidelines for the diagnosis and treatment of non-ST-elevation acute coronary syndromes. Eur Heart J 28:1598–1660

    Article  CAS  PubMed  Google Scholar 

  • Begley P, Francis-McIntyre S, Dunn WB, Broadhurst DI, Halsall A, Tseng A, Knowles J, Goodacre R, Kell DB, Consortium H (2009) Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale nontargeted metabolomic studies of human serum. Anal Chem 81(16):7038–7046

    Article  CAS  PubMed  Google Scholar 

  • Behar KL, Denhollander JA, Stromski ME, Ogino T, Shulman RG, Petroff OAC, Prichard JW (1983) High-resolution H-1 nuclear magnetic-resonance study of cerebral hypoxia in vivo. Proc Natl Acad Sci USA Biol Sci 80(16):4945–4948

    Article  CAS  Google Scholar 

  • Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95

    Article  Google Scholar 

  • Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842–1847

    CAS  PubMed  Google Scholar 

  • Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Boger SM (2000) LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 87:99–105

    CAS  PubMed  Google Scholar 

  • Brawer MK, Lange PH (1989) Prostate-specific antigen in management of prostatic carcinoma. Urology 33(5 Suppl):11–16

    Article  CAS  PubMed  Google Scholar 

  • Brindle JT et al (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8:1439–1444

    Article  CAS  PubMed  Google Scholar 

  • Broadhurst DI, Kell DB (2006) Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2(4):171–196

    Article  CAS  Google Scholar 

  • Brown M, Dunn WB, Ellis DI, Goodacre R, Handl J, Knowles JD, O’Hagan S, Spasic I, Kell DB (2005) A metabolome pipeline: From concept to data to knowledge. Metabolomics 1(1):39–51

    Article  CAS  Google Scholar 

  • Bruggeman FJ, Westerhoff HV (2007) The nature of systems biology. Trends Microbiol 15(1):45–50

    Article  CAS  PubMed  Google Scholar 

  • Bundy JG, Davey MP, Viant MR (2009) Environmental metabolomics: a critical review and future perspectives. Metabolomics 5(1):3–21

    Article  CAS  Google Scholar 

  • Cantor GH (2011) Metabolomics and mechanisms: sometimes the fisher catches a big fish. Toxicol Sci. doi:10.1093/toxsci/kfq297

  • Centerwall WR, Centerwall SA (1961) Phenylketonuria (FOLLING’s disease). The story of its discovery. J Hist Med Allied Sci 16:292–296

    Article  CAS  PubMed  Google Scholar 

  • Chace DH, Kalas TA (2005) A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem 38(4):296–309

    Article  CAS  PubMed  Google Scholar 

  • Chen Y, Zhang R, Song Y, He J, Sun J, Bai J, An Z, Dong L, Zhan Q, Abliz Z (2009) RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer. Analyst 134(10):2003–2011

    Article  CAS  PubMed  Google Scholar 

  • Classen S, Staratschek-Jox A, Schultze JL (2008) Use of genome-wide high-throughput technologies in biomarker development. Biomarker Med 2(5):509–523

    Article  CAS  Google Scholar 

  • de Lemos JA, McGuire DK, Drazner MH (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362:316–322

    Article  PubMed  CAS  Google Scholar 

  • Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur Heart J 29(19):2388–2442

    Article  CAS  PubMed  Google Scholar 

  • Dückelmann C, Mittermayer F, Haider DG, Altenberger J, Eichinger J, Wolzt M (2007) Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure. Arterioscler Thromb Vasc Biol 27(9):2037–2042

    Article  PubMed  CAS  Google Scholar 

  • Dückelmann C, Mittermayer F, Haider DG, Altenberger J, Wolzt M (2008) Plasma asymmetric dimethylarginine and cardiovascular events in patients with acute decompensated heart failure. Transl Res 152(1):24–30

    Article  PubMed  CAS  Google Scholar 

  • Dunckley T, Coon KD, Stephan DA (2005) Discovery and development of biomarkers of neurological disease. Drug Discovery Today 10(5):326–334

    Article  CAS  PubMed  Google Scholar 

  • Dunn WB, Bailey NJC, Johnson HE (2005) Measuring the metabolome: current analytical technologies. Analyst 130(5):606–625

    Article  CAS  PubMed  Google Scholar 

  • Dunn WB, Broadhurst DI, Deepak SM, Buch MH, McDowell G, Spasic G, Ellis DI, Brooks N, Neyses L, Kell DB (2007) Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics 3(4):413–426

    Article  CAS  Google Scholar 

  • Dunn WB, Broadhurst D, Atherton HJ, Goodacre R, Griffin JL (2011) Systems level studies of Mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. doi:10.1039/B906712B

  • Ellis DI, Goodacre R (2006) Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. Analyst 131:875–885

    Article  CAS  PubMed  Google Scholar 

  • Ellis DI, Dunn WB, Griffin JL, Allwood JW, Goodacre R (2007) Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 8:1243–1266

    Article  CAS  PubMed  Google Scholar 

  • Fernandes J, Saudubray JM, Berghe G van d Walter JH (2006) Inborn metabolic diseases diagnosis and treatment 4th, rev. ed., XXII, 561, p 65 illus., Hardcover ISBN: 978-3-540-28783-4

  • Fiehn O (2002) Metabolomics—the link between genotypes and phenotypes. Plant Mol Biol 48(1–2):155–171

    Article  CAS  PubMed  Google Scholar 

  • Folling A (1934) Ueber Ausscheidung von Phenylbrenztraubensaeure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillitaet. Ztschr Physiol Chem 227:169–176

    CAS  Google Scholar 

  • Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA (2003) N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24(19):1735–1743

    Google Scholar 

  • Go EP (2010) Database resources in metabolomics: an overview. J Neuroimmune Pharmacol 5(1):18–30

    Article  PubMed  Google Scholar 

  • Goodacre R (2007) Metabolomics of a superorganism. J Nutr 137:259S–266S

    CAS  PubMed  Google Scholar 

  • Goodacre R (2010) An overflow of… what else but metabolism! Metabolomics 6:1–2

    Google Scholar 

  • Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB (2004) Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 22(5):245–252

    Article  CAS  PubMed  Google Scholar 

  • Goto T, Takase H, Toriyama T, Sugiura T, Sato K, Ueda R, Dohi Y (2003) Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 89(11):1303–1307

    Article  CAS  PubMed  Google Scholar 

  • Griffin JL (2006) The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos Trans R Soc B Biol Sci 361(1465):147–161

    Article  CAS  Google Scholar 

  • Guan W, Zhou M, Hampton CY, Benigno BB, Walker LD, Gray A, McDonald JF, Fernández FM (2009) Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines. BMC Bioinform 10:259

    Google Scholar 

  • Hall RD (2006) Plant metabolomics: from holistic hope, to hype, to hot topic. New Phytol 169(3):453–468

    Article  CAS  PubMed  Google Scholar 

  • Hamada Y, Yamamura M, Hioki K, Yamamoto M, Nagura H, Watanabe K (1985) Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Correlation with plasma carcinoembryonic antigen levels. Cancer 55(1):136–141

    Google Scholar 

  • He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, Ling L (2004) Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429(6988):188–193

    Article  CAS  PubMed  Google Scholar 

  • Henkin TM (2008) Riboswitch RNAs: using RNA to sense cellular metabolism. Genes Dev 22(24):3383–3390

    Article  CAS  PubMed  Google Scholar 

  • Hollywood K, Brison DR, Goodacre R (2006) Metabolomics: current technologies and future trends. Proteomics 6(17):4716–4723

    Article  CAS  PubMed  Google Scholar 

  • Horning EC (1968) Use of combined gas-liquid chromatography and mass spectrometry for clinical problems. Clin Chem 14(8):777

    Google Scholar 

  • Howells SL, Maxwell RJ, Peet AC, Griffiths JR (1992) An investigation of tumor H-1 nuclear-magnetic-resonance spectra by the application of chemometric techniques. Magn Reson Med 28(2):214–236

    Article  CAS  PubMed  Google Scholar 

  • Hunt SA, Abraham WT, Chin MH et al (2005) ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult. American College of Cardiology. Circulation 112(12):e154–e235

    Google Scholar 

  • Issaq HJ, Nativ O, Waybright T, Luke B, Veenstra TD, Issaq EJ, Kravstov A, Mullerad M (2008) Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry. J Urol 179(6):2422–2426

    Article  CAS  PubMed  Google Scholar 

  • Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, Lein M, Jung K (2010) Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 58:12–18

    Article  CAS  PubMed  Google Scholar 

  • Kell DB (2006) Metabolomics, modelling, machine learning in systems biology: towards an understanding of the languages of cells. The 2005 Theodor Bücher lecture. FEBS J 273:873–894

    Article  CAS  PubMed  Google Scholar 

  • Kell DB (2007) Metabolomic biomarkers: search, discovery and validation. Exp Rev Mol Diagnost 7(4):329–333

    Article  CAS  Google Scholar 

  • Kell DB, Oliver SG (2004) Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. Bioessays 26:99–105

    Article  PubMed  Google Scholar 

  • Kenny LC, Broadhurst D, Brown M, Dunn WB, Redman CWG, Kell DB, Baker PN (2008) Detection and identification of novel metabolomic biomarkers in preeclampsia. Reproduct Sci 15:591–597

    Article  CAS  Google Scholar 

  • Kenny LC, Broadhurst DI, Dunn WB, Brown W, North RA, McCowan L, Roberts C, Cooper GJS, Kell DB, Baker PN (2010) Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 56:741–749

    Google Scholar 

  • Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, Thompson IM, Weiss RH (2009) Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cellular Proteom 8(3):558–570

    Article  CAS  Google Scholar 

  • Kind T, Tolstikov V, Fiehn O, Weiss RH (2007) A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 363(2):185–195

    Article  CAS  PubMed  Google Scholar 

  • Kirschenlohr HL, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, Clarke S, Schofield PM, McKilligin E, Mosedale DE, Grainger DJ (2006) Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med 12:705–710

    Article  CAS  PubMed  Google Scholar 

  • Kohler JP, Simonowitz D, Paloyan D (1980) Preoperative CEA level: a prognostic test in patients with colorectal carcinoma. Am Surg 46(8):449–452

    CAS  PubMed  Google Scholar 

  • Kuhara T (2007) Noninvasive human metabolome analysis for differential diagnosis of inborn errors of metabolism. J Chromatogr B Analyt Technol Biomed Life Sci 855(1):42–50

    Article  CAS  PubMed  Google Scholar 

  • Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, Farrell L, Asnani A, Cyrille M, Ramanathan A, Shaham O, Berriz G, Lowry PA, Palacios IF, Taşan M, Roth FP, Min J, Baumgartner C, Keshishian H, Addona T, Mootha VK, Rosenzweig A, Carr SA, Fifer MA, Sabatine MS, Gerszten RE (2008) Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 118(10):3503–3512

    Article  CAS  PubMed  Google Scholar 

  • Lindon JC, Nicholson JK (2008) Analytical technologies for metabonomics and metabolomics, and multi-omic information recovery. Trac-Trends Anal Chem 27(3):194–204

    Article  CAS  Google Scholar 

  • MacIntyre DA, Jiménez B, Lewintre EJ, Martín CR, Schäfer H, Ballesteros CG, Mayans JR, Spraul M, García-Conde J, Pineda-Lucena A (2010) Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia 24(4):788–797

    Article  CAS  PubMed  Google Scholar 

  • Madsen R, Lundstedt T, Trygg J (2010) Chemometrics in metabolomics—a review in human disease diagnosis. Anal Chim Acta 659(1–2):23–33

    Article  CAS  PubMed  Google Scholar 

  • Mamas M, Dunn W, Broadhurst D, Chacko S, Brown M, El-Omar M, Fath-Ordoubadi F, Clarke B, Goodacre R, Kell D, Neyses L (2009) Serum metabolomics identifies novel signature metabolites in very early cardiac ischaemia: first in human study. Circulation 120:S892

    Google Scholar 

  • Mashego MR, Rumbold K, De Mey M, Vandamme E, Soetaert W, Heijnen JJ (2007) Microbial metabolomics: past, present and future methodologies. Biotechnol Lett 29(1):1–16

    Article  CAS  PubMed  Google Scholar 

  • Monod J, Wyman J, Changeux JP (1965) On the nature of allosteric transitions: a plausible model. J Mol Biol 12:88–118

    Article  CAS  PubMed  Google Scholar 

  • Morrow DA, de Lemos JA (2007) Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 115:949–952

    Article  PubMed  Google Scholar 

  • Nam H, Chung BC, Kim Y, Lee K, Lee D (2009) Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics 25(23):3151–3157

    Article  CAS  PubMed  Google Scholar 

  • Nicholson JK (2006) Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol 2:52

    Article  PubMed  Google Scholar 

  • Nicholson JK, Lindon JC (2008) Systems biology—metabonomics. Nature 455(7216):1054–1056

    Article  CAS  PubMed  Google Scholar 

  • Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29(11):1181–1189

    Article  CAS  PubMed  Google Scholar 

  • Nicholson JK, Lindon JC, Holmes E, Wilson ID (2004) The challenges of modeling mammalian biocomplexity. Nat Biotechnol 22:1268–1274

    Article  CAS  PubMed  Google Scholar 

  • Nikolaidou T, Mamas M, Oceandy D, Neyses L (2010) Biological action of alpha-ketoglutarate in the heart and kidney—a metabolite identified through a metabolomic search in patients with heart failure. Eur J Heart Failure Suppl 9:S268

    Google Scholar 

  • Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, Geisler JP, Miller G, Sellers T, Cliby W et al (2005) Detection of epithelial ovarian cancer using H-1-NMR-based metabonomics. Int J Cancer 113(5):782–788

    Article  CAS  PubMed  Google Scholar 

  • Oliver SG, Winson MK, Kell DB, Baganz F (1998) Systematic functional analysis of the yeast genome. Trends Biotechnol 16(9):373–378

    Article  CAS  PubMed  Google Scholar 

  • Partington MW, Sinnott B (1964) Case finding in Phenylketonuria. II. The Guthrie test. Can Med Assoc J 91:105–114

    CAS  PubMed  Google Scholar 

  • Rashed MS (2001) Clinical applications of tandem mass spectrometry: ten years of diagnosis and screening for inherited metabolic diseases. J Chromatogr B Anal Technol Biomed Life Sci 758(1):27–48

    Article  CAS  Google Scholar 

  • Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB (2010) Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med 8:13

    Google Scholar 

  • Rocconi RP, Matthews KS, Kemper MK, Hoskins KE, Huh WK, Straughn JM Jr (2009) The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer. Gynecol Oncol 114(2):242–245

    Article  CAS  PubMed  Google Scholar 

  • Ross PL, Huang YLN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S et al (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cellular Proteom 3(12):1154–1169

    Article  CAS  Google Scholar 

  • Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, Berriz GF, Roth FP, Gerszten RE (2005) Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112(25):3868–3875

    Article  CAS  PubMed  Google Scholar 

  • Sahai I, Marsden D (2009) Newborn screening. Crit Rev Clin Lab Sci 46(2):55–82

    Article  CAS  PubMed  Google Scholar 

  • Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74(12):5463–5467

    Article  CAS  PubMed  Google Scholar 

  • Schalken JA (2010) Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development. Eur Urol 58(1):19–20

    Article  PubMed  Google Scholar 

  • Schauer N, Fernie AR (2006) Plant metabolomics: towards biological function and mechanism. Trends Plant Sci 11(10):508–516

    Article  CAS  PubMed  Google Scholar 

  • Schnackenberg LK, Beger RD (2008) The role of metabolic biomarkers in drug toxicity studies. Toxicol Mech Methods 18(4):301–311

    Article  CAS  PubMed  Google Scholar 

  • Shah SH, Bain JR, Muehlbauer MJ, Stevens RD, Crosslin DR, Haynes C, Dungan J, Newby LK, Hauser ER, Ginsburg GS, Newgard CB, Kraus WE (2010) Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet 3(2):207–214

    Article  CAS  PubMed  Google Scholar 

  • Smilde AK, Westerhuis JA, Hoefsloot HCJ, Bijlsma S, Rubingh CM, Vis DJ, Jellema RH, Pijl H, Roelfsema F, van der Greef J (2010) Dynamic metabolomic data analysis: a tutorial review. Metabolomics 6(1):3–17

    Article  CAS  PubMed  Google Scholar 

  • Spears M, Bartlett J (2009) The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer. Exp Opin Ther Targets 13(6):665–674

    Article  CAS  Google Scholar 

  • Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231):910–914

    Article  CAS  PubMed  Google Scholar 

  • Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M (2010) Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6(1):78–95

    Article  CAS  PubMed  Google Scholar 

  • The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction (2000) Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36:959–969

    Article  Google Scholar 

  • Tiziani S, Lopes V, Günther UL (2009) Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia 11(3):269–276

    CAS  PubMed  Google Scholar 

  • Tweeddale H, Notley-McRobb L, Ferenci T (1998) Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool (“Metabolome”) analysis. J Bacteriol 180(19):5109–5116

    CAS  PubMed  Google Scholar 

  • Urayama S, Zou W, Brooks K, Tolstikov V (2010) Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun Mass Spectrom 24(5):613–620

    Article  CAS  PubMed  Google Scholar 

  • van Dalen A, Favier J, Hallensleben E, Burges A, Stieber P, de Bruijn HW, Fink D, Ferrero A, McGing P, Harlozinska A, Kainz Ch, Markowska J, Molina R, Sturgeon C, Bowman A, Einarsson R, Goike H (2009) Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. Eur J Gynaecol Oncol 30(6):609–615

    PubMed  Google Scholar 

  • van der Werf MJ, Overkamp KM, Muilwijk B, Coulier L, Hankemeier T (2007) Microbial metabolomics: toward a platform with full metabolome coverage. Anal Biochem 370(1):17–25

    Article  PubMed  CAS  Google Scholar 

  • van Ravenzwaay B, Cunha GCP, Leibold E, Looser R, Mellert W, Prokoudine A, Walk T, Wiemer J (2007) The use of metabolomics for the discovery of new biomarkers of effect. Toxicol Lett 172(1–2):21–28

    Article  PubMed  CAS  Google Scholar 

  • Viant MR (2008) Recent developments in environmental metabolomics. Mol Biosyst 4(10):980–986

    Article  CAS  PubMed  Google Scholar 

  • Vinayavekhin N, Homan EA, Saghatelian A (2010) Exploring disease through metabolomics. ACS Chem Biol 5(1):91–103

    Article  CAS  PubMed  Google Scholar 

  • Wang Z, Tang WH, Cho L, Brennan DM, Hazen SL (2009) Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol 29(9):1383–1391

    Article  CAS  PubMed  Google Scholar 

  • Westerhoff HV, Palsson BO (2004) The evolution of molecular biology into systems biology. Nat Biotechnol 22(10):1249–1252

    Article  CAS  PubMed  Google Scholar 

  • Wilcken B (2007) Recent advances in newborn screening. J Inherit Metab Dis 30(2):129–133

    Article  CAS  PubMed  Google Scholar 

  • Wilcken B, Wiley V (2008) Newborn screening. Pathology 40(2):104–115

    Article  PubMed  Google Scholar 

  • Tang WWH, Tong W, Shrestha K, Wang Z, Levison BS, Delfraino B, Hu B, Troughton RW, Klein AL, Hazen SL (2008) Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. Eur Heart J 29(20):2506–2513

    Article  CAS  Google Scholar 

  • Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S et al (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37:D603–D610

    Article  CAS  PubMed  Google Scholar 

  • Woo HM, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC (2009) Mass spectrometry based metabolomic approaches in urinary biomarker study of women’s cancers. Clin Chim Acta 400(1–2):63–69

    Article  CAS  PubMed  Google Scholar 

  • World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. World Health Organization, Geneva

    Google Scholar 

  • Wu H, Xue R, Dong L, Liu T, Deng C, Zeng H, Shen X (2009) Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal Chim Acta 648(1):98–104

    Article  CAS  PubMed  Google Scholar 

  • Zelena E, Dunn WB, Broadhurst D, Francis-McIntyre S, Carroll KM, Begley P, O’Hagan S, Knowles JD, Halsall A, Wilson ID et al (2009) Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal Chem 81(4):1357–1364

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the support of the NIHR Manchester Biomedical Research Centre and The Manchester Academy Health Sciences Centre. WD and RG wish to thank the BBSRC for financial support of The Manchester Centre for Integrative Systems Biology (BB/C008219).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Royston Goodacre.

Additional information

The authors Mamas Mamas and Warwick B. Dunn are joint first authors contributing equally to the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mamas, M., Dunn, W.B., Neyses, L. et al. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol 85, 5–17 (2011). https://doi.org/10.1007/s00204-010-0609-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-010-0609-6

Keywords

Navigation